Literature DB >> 15567296

Evaluation of extrusion/spheronisation, layering and compaction for the preparation of an oral, multi-particulate formulation of viable, hIL-10 producing Lactococcus lactis.

Nathalie Huyghebaert1, An Vermeire, Sabine Neirynck, Lothar Steidler, Eric Remaut, Jean Paul Remon.   

Abstract

Three formulation techniques were compared in order to develop a multi-particulate formulation of viable, interleukin-10 producing Lactococcus lactis Thy12. First, freeze-dried L. lactis was compacted into mini-tablets. Next, liquid L. lactis culture was used as the granulation fluid for the production of pellets by extrusion/spheronisation. Finally, liquid L. lactis culture was layered on inert pellets as an alternative technique for the production of pellets. L. lactis viability and interleukin-10 production was evaluated. Viability dropped to 15.7% after compaction of freeze-dried L. lactis and to 1.0% after pelletisation of liquid L. lactis by extrusion/spheronisation. The viability in the mini-tablets and pellets, stored for 1 week at RT and 10% RH was reduced to 23 and 0.5% of initial viability, respectively. Storage for 1 week at RT and 60% RH resulted in complete loss of viability. Layering of L. lactis on inert pellets resulted in low viability (4.86%), but 1 week after storage at RT and 10% RH, 68% of initial viability was maintained. Increasing product temperature and cell density of L. lactis in the layering suspension did not significantly change viability after layering and storage. Interleukin-10 production capacity of L. lactis Thy12 was maintained after layering.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15567296     DOI: 10.1016/j.ejpb.2004.09.003

Source DB:  PubMed          Journal:  Eur J Pharm Biopharm        ISSN: 0939-6411            Impact factor:   5.571


  2 in total

1.  Importance of IL-10 modulation by probiotic microorganisms in gastrointestinal inflammatory diseases.

Authors:  Alejandra de Moreno de Leblanc; Silvina Del Carmen; Meritxell Zurita-Turk; Clarissa Santos Rocha; Maarten van de Guchte; Vasco Azevedo; Anderson Miyoshi; Jean Guy Leblanc
Journal:  ISRN Gastroenterol       Date:  2011-02-08

Review 2.  Applications of Genetically Modified Immunobiotics with High Immunoregulatory Capacity for Treatment of Inflammatory Bowel Diseases.

Authors:  Suguru Shigemori; Takeshi Shimosato
Journal:  Front Immunol       Date:  2017-01-25       Impact factor: 7.561

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.